Align Technology (ALGN) Competitors $125.79 -6.08 (-4.61%) Closing price 04:00 PM EasternExtended Trading$124.98 -0.81 (-0.64%) As of 05:48 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock ALGN vs. DXCM, HQY, HSIC, MEDP, QTRX, CAH, HAE, MCK, RMD, and WSTShould you be buying Align Technology stock or one of its competitors? The main competitors of Align Technology include DexCom (DXCM), HealthEquity (HQY), Henry Schein (HSIC), Medpace (MEDP), Quanterix (QTRX), Cardinal Health (CAH), Haemonetics (HAE), McKesson (MCK), ResMed (RMD), and West Pharmaceutical Services (WST). These companies are all part of the "medical" sector. Align Technology vs. Its Competitors DexCom HealthEquity Henry Schein Medpace Quanterix Cardinal Health Haemonetics McKesson ResMed West Pharmaceutical Services DexCom (NASDAQ:DXCM) and Align Technology (NASDAQ:ALGN) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, risk, media sentiment, valuation, profitability, analyst recommendations, earnings and dividends. Which has more volatility & risk, DXCM or ALGN? DexCom has a beta of 1.47, suggesting that its share price is 47% more volatile than the S&P 500. Comparatively, Align Technology has a beta of 1.7, suggesting that its share price is 70% more volatile than the S&P 500. Is DXCM or ALGN more profitable? DexCom has a net margin of 13.29% compared to Align Technology's net margin of 11.04%. DexCom's return on equity of 30.41% beat Align Technology's return on equity.Company Net Margins Return on Equity Return on Assets DexCom13.29% 30.41% 10.08% Align Technology 11.04%13.36%8.32% Does the media refer more to DXCM or ALGN? In the previous week, DexCom had 4 more articles in the media than Align Technology. MarketBeat recorded 21 mentions for DexCom and 17 mentions for Align Technology. DexCom's average media sentiment score of 0.89 beat Align Technology's score of 0.75 indicating that DexCom is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment DexCom 11 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive Align Technology 7 Very Positive mention(s) 0 Positive mention(s) 5 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive Which has stronger earnings & valuation, DXCM or ALGN? DexCom has higher revenue and earnings than Align Technology. Align Technology is trading at a lower price-to-earnings ratio than DexCom, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioDexCom$4.03B6.33$576.20M$1.4445.22Align Technology$3.96B2.30$421.36M$5.9321.21 Do analysts prefer DXCM or ALGN? DexCom presently has a consensus price target of $97.42, suggesting a potential upside of 49.60%. Align Technology has a consensus price target of $200.00, suggesting a potential upside of 59.00%. Given Align Technology's higher possible upside, analysts plainly believe Align Technology is more favorable than DexCom.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score DexCom 0 Sell rating(s) 6 Hold rating(s) 14 Buy rating(s) 3 Strong Buy rating(s) 2.87Align Technology 2 Sell rating(s) 7 Hold rating(s) 7 Buy rating(s) 1 Strong Buy rating(s) 2.41 Do insiders & institutionals have more ownership in DXCM or ALGN? 97.8% of DexCom shares are owned by institutional investors. Comparatively, 88.4% of Align Technology shares are owned by institutional investors. 0.3% of DexCom shares are owned by company insiders. Comparatively, 0.7% of Align Technology shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. SummaryDexCom beats Align Technology on 13 of the 17 factors compared between the two stocks. Get Align Technology News Delivered to You Automatically Sign up to receive the latest news and ratings for ALGN and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ALGN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ALGN vs. The Competition Export to ExcelMetricAlign TechnologyMED/DENTAL IndustryMedical SectorNASDAQ ExchangeMarket Cap$9.12B$15.41B$6.01B$10.23BDividend YieldN/A1.67%5.66%4.69%P/E Ratio21.2117.4685.3526.57Price / Sales2.302.09582.95179.01Price / Cash14.8113.1138.3262.20Price / Book2.443.0012.726.53Net Income$421.36M$472.95M$3.30B$275.87M7 Day Performance-4.83%-3.53%1.07%-1.40%1 Month Performance-5.38%-8.35%7.61%5.16%1 Year Performance-45.23%-13.59%79.71%31.51% Align Technology Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ALGNAlign Technology4.7801 of 5 stars$125.79-4.6%$200.00+59.0%-43.6%$9.12B$3.96B21.2120,945Analyst ForecastGap DownDXCMDexCom4.949 of 5 stars$66.46-1.0%$99.11+49.1%-2.2%$26.06B$4.03B46.1510,300Analyst ForecastHQYHealthEquity4.216 of 5 stars$95.34-1.2%$119.77+25.6%+10.6%$8.21B$1.20B57.783,120News CoveragePositive NewsAnalyst ForecastInsider TradeHSICHenry Schein3.998 of 5 stars$66.050.0%$76.67+16.1%-8.4%$8.01B$12.67B21.3125,000Analyst ForecastMEDPMedpace4.2557 of 5 stars$500.76+0.8%$422.27-15.7%+52.0%$14.07B$2.11B37.235,900Trending NewsAnalyst ForecastAnalyst RevisionQTRXQuanterix1.6995 of 5 stars$5.25+1.2%$11.75+123.8%-47.4%$243.97M$137.42M-2.88460News CoveragePositive NewsAnalyst ForecastCAHCardinal Health4.908 of 5 stars$154.79+0.7%$165.93+7.2%+37.3%$36.77B$222.58B24.0057,700News CoveragePositive NewsAnalyst ForecastAnalyst RevisionHAEHaemonetics4.931 of 5 stars$48.150.0%$78.78+63.6%-34.2%$2.32B$1.36B14.723,023News CoverageAnalyst ForecastAnalyst RevisionMCKMcKesson4.8729 of 5 stars$762.22+0.2%$829.08+8.8%+51.0%$94.80B$359.05B30.3945,000Positive NewsAnalyst ForecastAnalyst RevisionRMDResMed4.5955 of 5 stars$271.22+0.4%$294.20+8.5%+17.2%$39.71B$5.15B28.5210,600Positive NewsAnalyst ForecastInsider TradeWSTWest Pharmaceutical Services4.8864 of 5 stars$260.04-0.6%$318.56+22.5%-8.0%$18.70B$2.89B38.9310,600Positive NewsAnalyst Forecast Related Companies and Tools Related Companies DXCM Alternatives HQY Alternatives HSIC Alternatives MEDP Alternatives QTRX Alternatives CAH Alternatives HAE Alternatives MCK Alternatives RMD Alternatives WST Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ALGN) was last updated on 10/10/2025 by MarketBeat.com Staff From Our PartnersBitcoin grabs headlines, but smart money likes this tokenIf you're a futures trader (or want to be one), this could be the biggest shift you'll ever see in the prop fi...Neuro Street Trading Academy | SponsoredThe best AI stock you aren’t watching (but Elon is)Elon Musk's AI empire is already being built... not in the spotlight, but in the background. One public cou...Behind the Markets | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredU.S. Government Sparking Crypto RallyAltcoin ETFs could surge prices (do this now) My "Crypto Bull Run Millionaire Blueprint" breaks down exactl...Crypto 101 Media | Sponsored1 Hour Once A DayMy top income trading expert, Dave Aquino, just released a 1-hour trading strategy designed specifically to he...Base Camp Trading | SponsoredMiss This IRS Strategy Now, Regret It LaterWith Donald Trump back in the White House, many believe an economic revival could be underway — but it also br...American Alternative | SponsoredIs Nvidia about to Trigger Another 150X Opportunity?Nvidia gave investors a chance to make more than 150 times their money with its AI chips, known as graphics pr...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Align Technology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Align Technology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
